United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Engineers Gate Manager LP closes position in UTHR / United Therapeutics Corporation

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 0 shares of United Therapeutics Corporation (US:UTHR) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 20,539 shares of United Therapeutics Corporation. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -100.00 0
2026-02-17 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 20,539 2,644 14.78 10,008 33.41 0.1187
2025-11-14 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 17,895 464 2.66 7,502 49.78 0.0859
2025-08-14 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 17,431 11,250 182.01 5,009 162.89 0.0623
2025-05-15 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 6,181 963 18.46 1,905 3.48 0.0321
2025-02-14 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,218 645 14.10 1,841 12.39 0.0320
2024-11-14 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 4,573 -12,504 -73.22 1,639 -69.88 0.0320
2024-08-14 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 17,077 17,077 5,440 0.1227
2024-05-15 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -25,903 -100.00 0 -100.00
2024-02-14 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 25,903 22,991 789.53 5,696 766.82 0.1626
2023-11-14 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,912 -2,835 -49.33 658 -48.19 0.0243
2023-08-14 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,747 608 11.83 1,269 10.26 0.0480
2023-05-15 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,139 4,388 584.29 1,151 452.88 0.0481
2023-02-14 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 751 -1,519 -66.92 209 -56.21 0.0125
2022-11-14 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,270 -1,337 -37.07 475 -44.12 0.0296
2022-08-15 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,607 -293 -7.51 850 21.43 0.0312
2022-05-16 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,900 3,900 700 0.0274
2022-02-14 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -15,399 -100.00 0 -100.00
2021-11-15 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 15,399 13,989 992.13 2,842 1,023.32 0.1620
2021-08-16 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 1,410 -1,640 -53.77 253 -50.39 0.0163
2021-05-17 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,050 3,050 510 0.0253
2021-02-16 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -10,878 -100.00 0 -100.00
2020-11-16 2020-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,878 6,589 153.63 1,099 111.75 0.0516
2020-08-17 2020-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 4,289 4,289 519 0.0264
2020-05-15 2020-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -14,615 -100.00 0 -100.00
2020-02-14 2019-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 14,615 6,327 76.34 1,287 94.70 0.0566
2019-11-14 2019-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 8,288 508 6.53 661 8.90 0.0336
2019-08-14 2019-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 7,780 7,780 607 0.0335
2016-02-05 2015-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -2,710 -100.00 0 -100.00
2015-11-16 2015-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,710 2,710 356 0.0303
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.